TANGENT REPROFILING LIMITED

EC2Y 8AD (London)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£100,000

Jan 12 - May 13

Tangent Reprofiling - Combination therapies for hormone-dependent cancers. Utilising an innovative therapeutic strategy of drugs and nutritional supplements. Treating Prostate (and Ovarian, Breast and Endometrial) cancers beyond castration resistance.

Innovate UK award to TANGENT REPROFILING LIMITED

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}